HiFiBio partners with CoVIC for SARS-CoV-2 antibody therapies August 17, 2020 -- HiFiBio Therapeutics and the Coronavirus Immunotherapy Consortium (CoVIC) will collaborate to develop SARS-CoV-2-neutralizing antibodies with potential therapeutic and prophylactic applications.Read More